Now Available: Final Rule for FDAAA 801 and NIH Policy on Clinical Trial Reporting

Reduced Intensity Stem Cell Transplantation in Children With Relapsed Neuroblastoma After Autologous Transplantation

This study has been completed.
Sponsor:
Information provided by:
Samsung Medical Center
ClinicalTrials.gov Identifier:
NCT00793351
First received: November 17, 2008
Last updated: October 17, 2016
Last verified: November 2015
No Study Results Posted on ClinicalTrials.gov for this Study
  Study Status: This study has been completed.
  Study Completion Date: November 2015
  Primary Completion Date: November 2013 (Final data collection date for primary outcome measure)